← Back to Clinical Trials
Recruiting NCT05326880

NCT05326880 5-year Follow up Study on the Comparative Performance of Two-piece Zirconia and Titanium Implants

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05326880
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Dental Implants
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2022-01-03
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Ceramic Dental ImplantTitanium Dental Implant

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2022-01-03 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A post-market, randomized-controlled, superiority clinical study to compare medium-term performance and safety of the Straumann PURE 2-piece Ceramic Implant with Straumann Bone Level Implant using a fully digital workflow.

Eligibility Criteria

Inclusion Criteria: following criteria must be met for inclusion in the study: * Patients must have voluntarily signed the Informed Consent Form before any study related procedures are performed, are willing and able to attend scheduled follow-up visits and agree that the pseudonymized data will be collected, analyzed, and published. * Patients must be males or females who are a minimum of 18 years of age. * Patients, who have received a single tooth replacement with a study implant as per-protocol in the premolar-to-premolar area (excluding lower incisors) in the mandible and maxilla and restored with a screw retained ceramic crown. Exclusion Criteria: * Patients with conditions or circumstances, in the opinion of the Investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability. * Pregnancy or intention to become pregnant at any point during the study duration.

Contact & Investigator

Central Contact

Melissa R. Fok, Dr.

✉ melfok@hku.hk

📞 +852 2859 0301

Principal Investigator

Melissa R. Fok, Dr.

PRINCIPAL INVESTIGATOR

The University of Hong Kong

Frequently Asked Questions

Who can join the NCT05326880 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Dental Implants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05326880 currently recruiting?

Yes, NCT05326880 is actively recruiting participants. Contact the research team at melfok@hku.hk for enrollment information.

Where is the NCT05326880 trial being conducted?

This trial is being conducted at Düsseldorf, Germany, Hong Kong, Hong Kong.

Who is sponsoring the NCT05326880 clinical trial?

NCT05326880 is sponsored by The University of Hong Kong. The principal investigator is Melissa R. Fok, Dr. at The University of Hong Kong. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology